Impact of new cancer medicine - real-world evidence from Danish register study of lung cancer patients.
Jan H RudolfsenMads D HjortsøMikkel Hasse PedersenTrine PilgaardMette PøhlPublished in: Acta oncologica (Stockholm, Sweden) (2023)
Patients who received innovative new treatments had reduced risk of death and reduced risk of early retirement. Spouses of LC patients who received new treatments had lower healthcare costs in the years following diagnosis. All findings indicate that recipients of new treatments had reduced burden of illness.